Ronald Pabis

Ronald Pabis is a seasoned patent litigation attorney currently serving as a Partner at Tensegrity Law Group, where he focuses on representing technology companies and innovators in patent litigation, licensing, and other intellectual property disputes. His practice areas are broad, encompassing networking, semiconductors, semiconductor packaging, software, mechanical systems, and medical devices. He also has experience with communications, transportation, e-commerce, and optics technologies.

Throughout his career, Mr. Pabis has demonstrated experience representing both patent owners and accused infringers in federal district courts, before the U.S. International Trade Commission (ITC) in Section 337 investigations, and in arbitration panels. While his tracked appearances include a plaintiff-side role as of counsel for 10x Genomics, Inc. in 10x Genomics, Inc. et al. v. Element Biosciences, Inc., his broader profile indicates a balanced practice working for both plaintiffs and defendants. He has appeared before the Patent Trial and Appeal Board (PTAB) in inter partes review proceedings.

Mr. Pabis has been significantly involved in prominent patent disputes for high-technology clients. His work includes representing 10x Genomics, Inc. as a patent owner in several cases involving next-generation sequencing technology against companies such as Element Biosciences, Illumina Inc., and Curio Bioscience Inc. He was also involved in litigation where 10x Genomics secured a $31 million jury verdict and later a global cross-license agreement in a dispute with Bruker (formerly NanoString). Earlier in his career, Mr. Pabis practiced at other notable firms including Greenberg Traurig LLP, Goodwin Procter LLP, McDermott Will & Emery LLP, and Weil Gotshal & Manges LLP.

Mr. Pabis earned his J.D., cum laude, from Albany Law School of Union University in 1994, and a B.S. from Hobart and William Smith Colleges in 1988. He is admitted to practice in Florida and the District of Columbia, as well as before the United States Court of Appeals for the Federal Circuit and several U.S. District Courts.